Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr;23(4):629-631.
doi: 10.1002/ejhf.2173. Epub 2021 Apr 7.

Blood counts: targeting anaemia in patients with heart failure

Andreas P Kalogeropoulos  1 , Jessica Hotelling  1 , Hal A Skopicki  1
Affiliations
Free article
Editorial

Blood counts: targeting anaemia in patients with heart failure

Andreas P Kalogeropoulos et al. Eur J Heart Fail. 2021 Apr.
Free article
No abstract available

PubMed Disclaimer

Comment on

  • Effect of dapagliflozin on anaemia in DAPA-HF.
    Docherty KF, Curtain JP, Anand IS, Bengtsson O, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Schou M, Sjöstrand M, Solomon SD, Jhund PS, McMurray JJV; DAPA-HF Investigators and Committees. Docherty KF, et al. Eur J Heart Fail. 2021 Apr;23(4):617-628. doi: 10.1002/ejhf.2132. Epub 2021 Mar 22. Eur J Heart Fail. 2021. PMID: 33615642 Free PMC article. Clinical Trial.

References

    1. Chopra VK, Anker SD. Anaemia, iron deficiency and heart failure in 2020: facts and numbers. ESC Heart Fail 2020;7:2007-2011.
    1. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-827.
    1. Kang J, Park J, Lee JM, Park JJ, Choi DJ. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: a meta-analysis of randomized clinical trials. Int J Cardiol 2016;218:12-22.
    1. McMurray JJ, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CE, Merkely B, Nicolau JC, O'Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM; DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995-2008.
    1. Docherty KF, Curtain JP, Anand IS, Bengtsson O, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Schou M, Sjöstrand M, Solomon SD, Jhund PS, McMurray JJ; DAPA-HF Investigators and Committees. Effect of dapagliflozin on anaemia in DAPA-HF. Eur J Heart Fail 2021;23:617-628.

LinkOut - more resources